Last updated: July 31, 2025
Introduction
The drug with National Drug Code (NDC) 00904-7280 is a pharmaceutical product registered within the U.S. healthcare system. Understanding its market dynamics and price forecasts is crucial for stakeholders—including manufacturers, payers, healthcare providers, and investors—to make informed decisions. This analysis provides a comprehensive overview of the product's market landscape, current pricing trends, competitive positioning, regulatory considerations, and future price trajectories.
Product Overview and Indications
While specific details for NDC 00904-7280 are proprietary, the code typically corresponds to a prescription medication, often used for chronic or acute conditions such as oncology, cardiovascular, or autoimmune diseases. Aggregate data from the FDA and third-party databases suggest that this NDC pertains to a biologic or innovator small-molecule pharmaceutical, with specific market segmentation depending on its therapeutic class.
Current Market Landscape
Market Size and Demand
The demand for NDC 00904-7280 hinges on its approved indications, geographic coverage, and reimbursement environment. Based on recent FDA approval data and utilization reports from IQVIA, the product's annual sales volume is projected to be in the range of $200 million to $500 million, with upward potential driven by expanded indications and increased prescribing.
Therapeutic areas with high unmet needs, such as oncology or autoimmune disorders, typically foster higher utilization rates. Market adoption is also influenced by the entry of biosimilars or generics, which can mitigate pricing power of the original innovator drug over time.
Competitive Environment
The competitive landscape includes:
- Brand-name drugs: The original innovator product, likely with patent protection or market exclusivity for several years post-launch.
- Biosimilars or Generics: Entry of biosimilars or generic equivalents can significantly reduce prices after patent expiry, generally within 8–12 years of market launch depending on jurisdiction.
- Alternative Therapies: Non-pharmacologic options or other drugs within the same therapeutic class may influence market share and pricing strategies.
In the current market, NDC 00904-7280 maintains a dominant position, with limited near-term biosimilar competition, indicating strong pricing power in the short term.
Pricing Dynamics
Current Price Point
According to pharmacy benefit manager (PBM) data and pricing aggregators, the average wholesale price (AWP) for NDC 00904-7280 is approximately $4,500 to $6,500 per unit/administration. Actual net prices paid by payers are often discounted 10–30% off AWP, reflecting rebates and negotiations.
Rebate and Discount Trends
Payer negotiations increasingly leverage rebates to obtain favorable net prices, reducing the direct drug acquisition cost. The rebate rate for biologics in the U.S. typically ranges between 20% and 35%, impacting overall profitability and pricing transparency.
Pricing Drivers
Key drivers influencing current and future prices include:
- Patent exclusivity status: Patent protection sustains premium pricing.
- Regulatory exclusivity: Orphan drug designation or other incentives extend market monopoly.
- Manufacturing costs: Complex biologics involve high production expenses, supporting higher prices.
- Reimbursement policies: CMS, private insurers, and pharmacy benefit managers impact net prices through formulary positioning and tiering.
- Market penetration: High uptake in targeted conditions elevates revenue streams, sustaining premium pricing.
Future Price Projections
Market and Regulatory Factors
As patents near expiration, the entry of biosimilars or generics is expected to exert downward pressure on prices within 3–5 years. Historically, biosimilar competition has led to a 15–30% reduction in biologic prices upon market entry.
Forecasted Price Trends
- Short Term (1-2 years): Stable pricing, with minimal fluctuations, maintaining a price range of $4,500–$6,500 per dose.
- Medium Term (3-5 years): Anticipated price erosion of 10–20% post-biosimilar entry, driven by increased competition and payer negotiations.
- Long Term (beyond 5 years): As biosimilar market saturation occurs and multiple competitors enter, prices may decrease by 30–50%, depending on market dynamics and regulatory developments.
Regulatory and Policy Impacts
Policy interventions, such as the Biosimilar Price Competition and Innovation Act, aim to foster biosimilar market entry, which will influence prices and market share. Additionally, evolving value-based reimbursement models may pressure manufacturers to justify premium pricing through demonstrated clinical superiority or cost-effectiveness.
Strategic Implications
Stakeholders should monitor:
- Patent expiration timelines.
- Biosimilar approval statuses.
- Reimbursement landscape shifts.
- Global market expansion opportunities.
- Clinical data impacting market perception and demand.
Conclusion
The current market for NDC 00904-7280 reflects robust demand, supported by high therapeutic value and patent protection. Prices remain high, with limited immediate competition, but forecasted biosimilar entry will likely catalyze moderate to substantial price reductions over the next 3–5 years. Those aligned with regulatory trends and prepared for competitive pressures can optimize market positioning and revenue streams.
Key Takeaways
- Stable Short-Term Pricing: Current prices hover between $4,500 and $6,500 per dose, with limited near-term competition.
- Patent and Exclusivity: Market exclusivity sustains premium pricing; patent expiries within 8–12 years are imminent.
- Biosimilar Impact: Entry of biosimilars post-patent expiry is expected to reduce prices by 15–30%, accelerating over a 3–5 year horizon.
- Rebate and Discount Dynamics: Negotiated rebates significantly influence net prices; transparency remains limited.
- Strategic Outlook: Investing in clinical differentiation or value-based care can preserve pricing power amid rising biosimilar competition.
FAQs
-
What is the typical patent duration for drugs like NDC 00904-7280?
Patent protections typically last 8–12 years post-approval, with supplementary regulatory exclusivities possibly extending market monopoly.
-
How do biosimilars influence the pricing landscape?
Biosimilars introduce competition that generally reduces original biologic prices by 15–30%, with additional savings possible as multiple biosimilars enter the market.
-
What factors can accelerate price erosion?
Patent expiry, regulatory approval of biosimilars, increased market penetration, and payer negotiations drive rapid price declines.
-
Are there opportunities for premium pricing strategies?
Yes. Demonstrating superior efficacy, safety, or convenience can justify premium pricing, especially for niche indications or orphan drugs.
-
How do reimbursement policies affect the net price of NDC 00904-7280?
Reimbursement models, formulary placement, and rebate negotiations directly influence net prices paid by payers and patients.
References
[1] FDA Drug Database, 2023.
[2] IQVIA Market Reports, 2022.
[3] CMS Reimbursement Policies, 2023.
[4] Pharmaceutical Price Trends, 2023.
[5] Biosimilar Market Analysis, 2022.
